Altered dose response to β-agonists in SERCA1a-expressing hearts ex vivo and in vivo

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 3 52-3, 2002, Pages

  Huke, Sabine ^a   Prasad, Vikram ^a   Nieman, Michelle L ^b   Nattamai, Kalpana J ^a   Grupp, Ingrid L ^b   Lorenz, John N ^b   Periasamy, Muthu ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Contractility; Phospholamban; Sarco(endo)plasmic reticulum calcium adenosinetriphosphatase; Transgenic mice

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ION; DOBUTAMINE; PHOSPHOLAMBAN; PROTEIN SERCA 1A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; ENDOPLASMIC RETICULUM; FEMALE; HEART CONTRACTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HORMONAL REGULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOPLASMIC RETICULUM; TRANSGENIC MOUSE;

EID: 0036353388     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00078.2002     Document Type: Article

References (36)

1. Fractional SRCa release is regulated by trigger Ca and SRCa content in cardiac myocytes
2. A practical guide to the preparation of Ca buffers
3. Role of protein phosphatases in regulation of cardiac inotropy and relaxation
4. Phospholamban and cardiac contractile function
5. 2+ activation and inactivation sites on the luminal side of the cardiac ryanodine receptor complex
6. 16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to β-agonists
7. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a
8. αq-mediated cardiac hypertrophy and ventricular dysfunction
9. 16 phosphorylation in cardiac myocytes
10. Characterization of the molecular form of cardiac phospholamban
11. Alterations of calcium-regulatory proteins in heart failure
12. Frequency-dependent changes in calcium cycling and contractile activation in SERCA2a transgenic mice
13. 2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation
14. Abnormalities of calcium cycling in the hypertrophied and failing heart
15. 2+ homeostasis and cardiomyocyte function
16. SERCA1a can functionally substitute for SERCA2a in the heart
17. Decreased cardiac SERCA2 calcium pump activity results in decreased phospholamban protein levels and increased compensatory phosphorylation at phospholamban residues Ser-16 and Thr-17
18. Phospholamban inhibitory function is activated by depolymerization
19. 2+ handling capacity
20. Phosphorylation of phospholamban and troponin I in β-adrenergic-induced acceleration of cardiac relaxation
21. Regulatory effects of phospholamban on cardiac function in intact mice
22. Measurement of intraventricular pressure and cardiac performance in the intact closed-chest anesthetized mouse
23. 2+-ATPase
24. Regulation of calcium release by calcium inside the sarcoplasmic reticulum in ventricular myocytes
25. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation
26. Gene therapy for common acquired diseases of the heart: The Sirens' song
27. 2+-ATPase overexpression by adenovirus mediated gene transfer and in transgenic mice
28. Adenoviral gene transfer of SERCA2a improves left ventricular function in aortic-banded rats in transition to heart failure
29. 2+ homeostasis and cardiac contractility
30. i restores uncoupled β-adrenergic signaling in isolated perfused transgenic mouse hearts
31. Potentiation of fractional sarcoplasmic reticulum calcium release by total and free intra-sarcoplasmic reticulum calcium concentration
32. Phospholamban: Protein structure, mechanism of action, and role in cardiac function
33. 2+ transport and muscle relaxation
34. Comparison of SERCA1 and SERCA2a expressed in COS-1 cells and cardiac myocytes
35. 2+-ATPase of sarcoplasmic reticulum that affect functional association with phospholamban